Skip to main content
. 2010 Jun 28;54(9):3804–3811. doi: 10.1128/AAC.00351-10

TABLE 3.

Unusuala antimicrobial resistance phenotypes and resistance genes identified in USA300 isolates

Resistance phenotype (drug or drug combination)b No. of isolatesc No. of isolates with the following genetic determinant detected by PCR:
Source(s) of isolates
ermC mupA aac2′-aph6" dfrA tetM pSK41d
CC 42 42 0 0 3 0 1 CA, CT, GA, NY, OR, TN
MUP 12 0 12 0 1 0 9 CA, GA, NY, OR
CC + MUP 5 5 5 0 0 0 5 CA, GA, OR
GM 1 0 0 1 1 0 0 CA
GM + TMP-SMZ 3 0 0 3 3 0 3 CA, TN
GM + MUP 4 0 4 4 1 0 4 GA, PA, TN
MUP + TMP-SMZ 1 0 1 0 0 0 1 OR
CC + TMP-SMZ 1 1 0 0 1 0 0 OR
CC + DOX 2 2 0 0 0 2 1 GA, OR
CC + MUP + DOX 1 1 1 0 0 1 1 TN
Total 72 51 23 8 10 3 25
a

Likely plasmid-mediated resistance to clindamycin, mupirocin, gentamicin, trimethoprim-sulfamethoxazole, and/or doxycycline.

b

CC, clindamycin resistance (10 isolates had inducible resistance, and 41 had constitutive resistance); MUP, high-level mupirocin resistance; GM, gentamicin resistance; DOX, doxycycline resistance.

c

The total number of isolates was 72 (8.7% of the isolates in this study).

d

The presence of pSK41 was identified by positive PCR for traE, traI, and repA.